Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1465 Articles

Jon C. Ogg | Nov 8, 2018 at 12:45 PM EST

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to…

Paul Ausick | Nov 7, 2018 at 4:01 PM EST

UnitedHealth, Caterpillar Launch the Dow Higher Wednesday

Caterpillar, UnitedHealth, Microsoft, and Pfizer lifted the down to 500-point gain Wednesday.

Chris Lange | Nov 6, 2018 at 11:50 AM EST

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Nektar shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer to evaluate several combination…

Paul Ausick | Nov 2, 2018 at 4:01 PM EDT

Apple, Intel Tank the Dow Friday

Apple, Intel, Pfizer, and Merck were the worst performing Dow stocks on Friday.

Jon C. Ogg | Nov 1, 2018 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: American Eagle, Facebook, Nutrisystem, Pfizer, Roku, SeaWorld, Valero, Zynga and More

The top analyst upgrades, downgrades and initiations seen on Thursday included American Eagle Outfitters, Facebook, Nutrisystem, Pfizer, Roku, SeaWorld, Valero…

Chris Lange | Oct 30, 2018 at 8:40 AM EDT

Why Pfizer Is Tripping Over Itself With Earnings

Pfizer reported mixed quarterly results before the markets opened on Tuesday and shares retreated in the premarket.

Chris Lange | Oct 29, 2018 at 11:25 AM EDT

What to Watch For When Pfizer Reports Tuesday Morning

Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.

Chris Lange | Oct 28, 2018 at 7:20 AM EDT

Apple, Exxon, Pfizer and More Dow Earnings to Watch For

24/7 Wall St. has put together a preview of the Dow companies scheduled to report their quarterly results this week.…

Chris Lange | Oct 25, 2018 at 9:00 AM EDT

Major Pharma Short Sellers Hike Their Bets

The October 15 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Oct 25, 2018 at 7:10 AM EDT

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

These four top pharmaceutical companies have longstanding franchises with huge sales and revenues, and their dividend-paying stocks look like outstanding choices…

Chris Lange | Oct 23, 2018 at 1:15 PM EDT

Pfizer and Bain Capital Partner Up to Tackle CNS Disorders

Pfizer, in collaboration with Bain Capital, announced the creation of Cerevel Therapeutics, a new biopharmaceutical company focused on developing drug…

Paul Ausick | Oct 20, 2018 at 8:55 AM EDT

Apple Again Top-Performing Dow Stock, but Merck Is Closing In

Apple shares dipped again last week, but the company managed to hold onto its rank as the top-performing Dow stock…

Paul Ausick | Oct 14, 2018 at 9:05 AM EDT

9 Dow Components Up by Double Digits

In 2017, 20 of the 30 stocks that comprise the Dow Jones Industrial Average posted double-digit, year-over-year share price gains.…

Paul Ausick | Oct 11, 2018 at 4:01 PM EDT

Chevron, Exxon Hammer the Dow Thursday

For the second consecutive trading day, all 30 Dow stocks closed lower Thursday. Exxon, Chevron, Pfizer, and McDonald's were the…

Chris Lange | Oct 10, 2018 at 9:10 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

1 … 30 31 32 33 34 … 98

Pfizer : PFE

All Pfizer Articles

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

UnitedHealth, Caterpillar Launch the Dow Higher Wednesday

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Apple, Intel Tank the Dow Friday

Top Analyst Upgrades and Downgrades: American Eagle, Facebook, Nutrisystem, Pfizer, Roku, SeaWorld, Valero, Zynga and More

Why Pfizer Is Tripping Over Itself With Earnings

What to Watch For When Pfizer Reports Tuesday Morning

Apple, Exxon, Pfizer and More Dow Earnings to Watch For

Major Pharma Short Sellers Hike Their Bets

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

Pfizer and Bain Capital Partner Up to Tackle CNS Disorders

Apple Again Top-Performing Dow Stock, but Merck Is Closing In

9 Dow Components Up by Double Digits

Chevron, Exxon Hammer the Dow Thursday

Short Sellers Run for Cover From Major Pharma

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

This High-Yield Emerging Funds ETF Offers International Diversification

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

Pfizer : PFE

All Pfizer Articles

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

UnitedHealth, Caterpillar Launch the Dow Higher Wednesday

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Apple, Intel Tank the Dow Friday

Top Analyst Upgrades and Downgrades: American Eagle, Facebook, Nutrisystem, Pfizer, Roku, SeaWorld, Valero, Zynga and More

Why Pfizer Is Tripping Over Itself With Earnings

What to Watch For When Pfizer Reports Tuesday Morning

Apple, Exxon, Pfizer and More Dow Earnings to Watch For

Major Pharma Short Sellers Hike Their Bets

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

Pfizer and Bain Capital Partner Up to Tackle CNS Disorders

Apple Again Top-Performing Dow Stock, but Merck Is Closing In

9 Dow Components Up by Double Digits

Chevron, Exxon Hammer the Dow Thursday

Short Sellers Run for Cover From Major Pharma

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

This High-Yield Emerging Funds ETF Offers International Diversification

Featured Reads

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month